Since its establishment in 2002, Celltrion has always set its sight on the global market. Through a meticulous step-by-step business strategy ranging from acquisition of platform technologies and infrastructure to the development of new proprietary drugs, Celltrion is attaining global competitiveness with major biopharmaceutical companies. Our mission to provide cost-effective healthcare benefits to patients worldwide will continue without end.